Effects of Lateral Pharma compounds in COPD, Asthma, COVID models and in vitro experiments

Project Member(s): Hansbro, P.

Funding or Partner Organisation: Lateral Pharma Pty Ltd
Lateral Pharma Pty Ltd

Start year: 2021

Summary: Lateral Pharma want to test their peptides in our mouse models of lung inflammation

FOR Codes: Cardiovascular medicine and haematology, Respiratory System and Diseases (incl. Asthma), Infectious Diseases, Cardiorespiratory Medicine and Haematology, Clinical health

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.